Agilon Health, Inc. (AGL)
115.66
+5.36
(+4.86%)
USD |
NYSE |
Nov 13, 16:00
115.65
-0.01
(-0.01%)
After-Hours: 19:59
Agilon Health Gross Profit Margin (Quarterly) : 6.00% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 6.00% |
| June 30, 2026 | 6.71% |
| March 31, 2026 | 4.10% |
| December 31, 2025 | -6.22% |
| September 30, 2025 | -5.23% |
| June 30, 2025 | -4.28% |
| March 31, 2025 | 2.86% |
| December 31, 2024 | -2.94% |
| September 30, 2024 | -4.85% |
| June 30, 2024 | 1.77% |
| March 31, 2024 | 4.32% |
| December 31, 2023 | -9.43% |
| September 30, 2023 | 2.88% |
| June 30, 2023 | 4.70% |
| Date | Value |
|---|---|
| March 31, 2023 | 6.66% |
| December 31, 2022 | 2.15% |
| September 30, 2022 | 3.23% |
| June 30, 2022 | 4.61% |
| March 31, 2022 | 5.98% |
| December 31, 2021 | 1.29% |
| September 30, 2021 | 2.41% |
| June 30, 2021 | 3.85% |
| March 31, 2021 | 6.21% |
| December 31, 2020 | 0.50% |
| September 30, 2020 | 7.06% |
| June 30, 2020 | 11.97% |
| March 31, 2020 | 7.48% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Astrana Health, Inc. | 10.54% |
| Starling Oncology, Inc. | 17.17% |
| Nakamoto, Inc. | -- |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | 75.40% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -47.25% |
| Return on Assets | -7.05% |
| Return on Invested Capital | -40.91% |
| Profit Margin (Quarterly) | 2.30% |
| Operating Margin (Quarterly) | 1.80% |
| Return on Net Operating Assets | -107.9% |